GlassScriptPhysician profile
Stacey S Hodges
NPI 1104814805
$4,018.35
in general payments reported to CMS, 2019-2025
13 companies · $2,190 in 2025
The $2,190 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $647 · 2022: $1,053 · 2023: $129 · 2025: $2,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,031 · Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,031.30 |
| Food and Beverage | $287.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $2,031.30 | 2025 | |
| Abbvie INC. | $752.20 | 2021-2023 | |
| Janssen Biotech, INC. | $397.22 | 2021-2023 | Simponi Aria, Remicade, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $276.48 | 2021-2025 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $183.28 | 2022 | |
| Janssen Scientific Affairs, LLC | $133.68 | 2022 | |
| Medtronic, INC. | $98.94 | 2022 | |
| Pfizer INC. | $52.96 | 2021-2025 | |
| Evoke Pharma, INC. | $24.60 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.50 | 2021 | |
| Gilead Sciences, INC. | $16.08 | 2021 | |
| Ardelyx, INC. | $14.51 | 2022 | |
| Celgene Corporation | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.